EFEMP1 has also been reported to activate Notch signaling in vitro, although with less efficiency than JAG1 [39], and to exert both tumor suppressive and oncogenic effects in various cancers by participating in multiple signaling pathways [40–43]. The gene discussed is JAG1; the disease is cancer.